Objectives
Anti-neutrophil cytoplasmic antibody (ANCA) vasculitis is a complex disease, with much debate about the utility of systems for classification and diagnosis. We compared three currently used classification systems in predicting disease prognosis.
Methods
Three classification systems were applied to 502 patients with biopsy proven ANCA vasculitis: the Chapel Hill Consensus Conference (CHCC) definition with categories for granulomatosis with polyangiitis (GPA, Wegener’s granulomatosis), microscopic polyangiitis (MPA) and the Kidney Limited Disease (KLD); European Medicines Agency (EMA) system with categories for GPA and MPA, and classification based on ANCA specificity (PR3 versus MPO). Outcomes included treatment resistance, relapse, end stage kidney disease (ESKD) and death. Proportional hazards models were compared between systems using an information-theoretic approach to rank models by predictive fit. Hazard Ratios (HR) with 95% confidence intervals (CI) and p-values are reported.
Results
ANCA specificity was predictive of relapse, with PR3-ANCA patients almost twice as likely as those with MPO-ANCA to relapse (HR=1.89, 95% CI=1.33–2.69, p=0.0004), and ANCA specificity had the best predictive model fit (Model Rank=1) compared to CHCC and EMA. CHCC and EMA systems did not predict relapse. By ANCA specificity, categories of GPA, MPA and KLD did not distinguish differences in probability of relapse-free survival. None of the systems predicted treatment resistance, ESKD or death.
Conclusion
ANCA specificity independently predicts relapse among patients with ANCA vasculitis with renal disease. Classification and diagnostic systems that incorporate ANCA specificity, such as PR3-ANCA-MPA and MPO-ANCA-MPA, provide a more useful tool for predicting relapse than the clinic pathologic category alone.
This study delineates a role for genetic testing for NPHS2 in children with biopsy-proven sporadic FSGS. Further studies which specify clinical and pathological details of patients will help further define whether there are specific populations that warrant systematic testing of other podocyte-related genes in sporadic FSGS.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.